NOVADIP BIOSCIENCES has a total of 21 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are GUANGZHOU RAINHOME PHARM & TECH CO LTD, BONUS THERAPEUTICS LTD and IMEDEX.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Singapore | 2 | |
#8 | Taiwan | 2 | |
#9 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dufrane Denis | 19 |
#2 | Denis Dufrane | 2 |
Publication | Filing date | Title |
---|---|---|
AU2019342877A1 | Biomaterial comprising adipose-derived stem cells and gelatin and method for producing the same | |
US2019083680A1 | Biomaterial comprising adipose-derived stem cells and method for producing the same | |
TW201919720A | Biomaterial comprising adipose-derived stem cells and method for producing the same | |
SG11202001586YA | Biomaterial comprising adipose-derived stem cells and method for producing the same |